Prostaglandin I2 + Placebo
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes Mellitus
Conditions
Type 2 Diabetes Mellitus, Peripheral Microvascular Symptoms
Trial Timeline
Jan 1, 2010 → Oct 1, 2010
NCT ID
NCT01061060About Prostaglandin I2 + Placebo
Prostaglandin I2 + Placebo is a approved stage product being developed by Astellas Pharma for Type 2 Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT01061060. Target conditions include Type 2 Diabetes Mellitus, Peripheral Microvascular Symptoms.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01061060 | Approved | Completed |
Competing Products
20 competing products in Type 2 Diabetes Mellitus